Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Adolescents with severe alopecia incur significantly higher healthcare costs.

α-Ketoglutaric acid improves hair growth, rabbit performance, and antioxidant levels.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

People with alopecia areata are more likely to have thyroid autoimmunity, but not thyroid disease.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

Baricitinib may effectively treat nail changes in alopecia areata.

IL-15 and TNF-α levels are higher in alopecia areata patients, especially in alopecia totalis.

Clinical trials for alopecia areata need better inclusion and retention of patients of color.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Consider cultural practices and barriers for effective alopecia areata treatment.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Baricitinib is a safe and effective treatment for severe alopecia areata.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Baricitinib can cause excessive hair growth.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

Alopecia areata causes hair loss and needs personalized care to manage its emotional and social effects.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Over half of physiotherapy students in Lahore experience hair loss, highlighting the need for better education and early treatment.

Ayurvedic treatment significantly reduced alopecia areata symptoms.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

Actinic keratosis is a sun-induced skin condition that can potentially turn into skin cancer and requires various treatments to prevent this.

Actinic keratosis is a sun-induced skin condition that can potentially turn into skin cancer and requires treatment to prevent malignancy.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Baricitinib helps regrow hair in teens with severe alopecia areata.